138 related articles for article (PubMed ID: 10933975)
1. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
Su H; Lu R; Ding R; Kan YW
Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy against an experimental glioma using adeno-associated virus vectors.
Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments.
Coll JL; Mesnil M; Lefebvre MF; Lancon A; Favrot MC
Gene Ther; 1997 Nov; 4(11):1160-6. PubMed ID: 9425438
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL
Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice.
Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T
Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene.
Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T
Anticancer Res; 1996; 16(5A):2623-8. PubMed ID: 8917361
[TBL] [Abstract][Full Text] [Related]
12. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
13. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration.
Tong XW; Block A; Chen SH; Contant CF; Agoulnik I; Blankenburg K; Kaufman RH; Woo SL; Kieback DG
Gynecol Oncol; 1996 May; 61(2):175-9. PubMed ID: 8626129
[TBL] [Abstract][Full Text] [Related]
14. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM
Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells.
Takenaga K; Tagawa M; Sakiyama S
Anticancer Res; 1996; 16(2):681-5. PubMed ID: 8687114
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis of the 'bystander effect': a cytokine cascade.
Ramesh R; Marrogi AJ; Munshi A; Abboud CN; Freeman SM
Exp Hematol; 1996 Jun; 24(7):829-38. PubMed ID: 8647234
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment.
Ishii-Morita H; Agbaria R; Mullen CA; Hirano H; Koeplin DA; Ram Z; Oldfield EH; Johns DG; Blaese RM
Gene Ther; 1997 Mar; 4(3):244-51. PubMed ID: 9135738
[TBL] [Abstract][Full Text] [Related]
18. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.
Brand K; Arnold W; Bartels T; Lieber A; Kay MA; Strauss M; Dörken B
Cancer Gene Ther; 1997; 4(1):9-16. PubMed ID: 9012446
[TBL] [Abstract][Full Text] [Related]
19. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma.
Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T
Hepatology; 1995 Dec; 22(6):1838-46. PubMed ID: 7489996
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V).
Pavlovic J; Nawrath M; Tu R; Heinicke T; Moelling K
Gene Ther; 1996 Jul; 3(7):635-43. PubMed ID: 8818652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]